Skip to Main Content
Skip Nav Destination


DOCEtaxel

Basics

Name

DOCEtaxel

Pronunciation

(doe se TAKS el)

Brand Names: US

  • Docivyx

Therapeutic Category

  • Antineoplastic Agent, Antimicrotubular
  • Antineoplastic Agent, Taxane Derivative

Medication Safety Issues

Sound-alike/look-alike issues:

DOCEtaxel may be confused with cabazitaxel, PACLitaxel (conventional), PACLitaxel (protein bound).

Taxotere may be confused with Abraxane, Taxol.

High alert medication:

The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes (chemotherapeutic agent, parenteral and oral) which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care, Community/Ambulatory Care, and Long-Term Care Settings).

Administration issues:

Multiple concentrations: Docetaxel is available at concentrations of 10 mg/mL (generic formulation) and 20 mg/mL (concentrate/solution). Admixture errors have occurred due to the availability of various docetaxel concentrations.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal